Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience

INTRODUCTION: Minimal residual disease (MRD), detected based on immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements as markers of residual leukemic cells, is currently the most reliable prognostic factor in acute lymphoblastic leukemia (ALL). A feasibility study is presented of the stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawidowska, Małgorzata, Jółkowska, Justyna, Szczepański, Tomasz, Derwich, Katarzyna, Wachowiak, Jacek, Witt, Michał
Formato: Texto
Lenguaje:English
Publicado: Birkhäuser-Verlag 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805919/
https://www.ncbi.nlm.nih.gov/pubmed/19043668
http://dx.doi.org/10.1007/s00005-008-0045-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805919/
https://www.ncbi.nlm.nih.gov/pubmed/19043668
http://dx.doi.org/10.1007/s00005-008-0045-y

Ejemplares similares